🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.Ashish Saxena, MD, PhD and nasser altorki are speaking about multidisciplinary #LungCancer treatment PER’s 19th Annual New York Lung Cancers Symposium on 11/16. Weill Cornell Medicine team members can get free registration – DM us for the code and learn more here: bit.ly/4e5TXmF

November is #LungCancerAwarenessMonth. #LungCancer symptoms don’t show up the same way for everyone and may not appear at all, but these are some of the main ones to keep on your radar. #LCSM

The most common form of #LungCancer is non-small cell lung cancer (#NSCLC) which usually originates in the lung tissue. #LungCancerAwarenessMonth #LCSM

Dr. Ashish Saxena presenting a challenging case of a pt w/ high PDL1 lung cancer w/ ILD & autoimmune disease at PER #gotoPER #NYLung24 WCM Lung Cancer Ashish Saxena, MD, PhD

Challenging cases at #NYLung24 with a super⭐️ panel, including Weill Cornell Medicine #ThoracicOncologist extraordinaire Ashish Saxena, MD, PhD 🫁 WCM Lung Cancer Weill Cornell Medicine Cardiothoracic Surgery Weill Cornell Medicine Meyer Cancer Center Christine Garcia, MD, MPH @JonvillenaM nasser altorki

A less common form of #LungCancer called #SmallCellLungCancer is more fast growing and typically starts in breathing tubes #LungCancerAwarenessMonth #LCSM

There are a variety of treatment options available to patients with #LungCancer, depending on the type, stage, and specifics of the #cancer. Our Weill Cornell Medicine NewYork-Presbyterian team offers these options and more to patients: bit.ly/3DqxWif #LungCancerAwarenessMonth

Congrats to all the EGFR Resisters Research Summit award winners! Especially Bobak Parang- WCM Lung Cancer and former@WCMHemOncFellow!

Check out work by Drs. Dan & Laura Libby with Ashish Saxena, MD, PhD on recurrence with stage I lung cancer w/ driver mutations. WCM Lung Cancer #lcsm

This year’s World Cancer Day theme is "United by Unique." Our collaborative approach to cancer care ensures patients receive top evaluations and therapies, including advancements in precision medicine and immune-based treatments. We make the fight against cancer personal.

"Real world cancer treatment patterns and their effects on survival in older adults w/ lung cancer: A SEER-MHOS analysis" presented by Shuyan Qiu #AACR25 #AACR2025 Weill Cornell Medicine Population Health Sciences WCM Lung Cancer

Luchang Cui presented our Weill Cornell Medicine Meyer Cancer Center Molecularly Enhanced Lung Cancer Database (MELD) at #AACR25 - this platform integrates clinical, molecular & environmental data using NLP! More to come from this collaboration w/ Weill Cornell Medicine Population Health Sciences WCM Lung Cancer & Weill Cornell Medicine Pathology! #LCSM

Such an inspiring day at the 2025 American Lung Association LUNG FORCE Walk! Deeply honored to be the Medical Honoree. Huge thanks to the incredible WCM Lung Cancer team AND all the amazing supporters who walked & donated! Every step was for our patients and a future with a cure. #lcsm

Thanks to Dr. Despina Siolas, MD, PhD & #SiolasLab for supporting the American Lung Association LUNG FORCE Walk! Great to have you all part of the WCM Lung Cancer team!

Thanks PIX11 News for highlighting the 2025 American Lung Association LUNG FORCE walk to raise money to fight lung disease WCM Lung Cancer pix11.com/video/hundreds…

Clinical research Weill Cornell Medicine NewYork-Presbyterian is dedicated to innovating, inspiring and transforming lives. On #ClinicalTrialsDay, some of our team members who support clinical research are sharing how we are Powered By Purpose. #CTD2025 ACRP - Assoc. of Clinical Research Profession

Very excited to join this awesome crew for the OncLive.com National Fellows Forum on #lungcancer and meet with future thoracic oncologists! pre-#ASCO25! WCM Lung Cancer WCMHemOncFellow Eric K. Singhi, MD Narjust Florez, MD, FASCO Sandip Patel MD FASCO

2nd year WCMHemOncFellow Dr. Jonathan Lee (@jonathanwlee23) led his OncLive.com fellows’ team, THORacic AvEnGeRs to discuss the effect of PDL1 on outcomes for patients w/ #EGFR lung cancer! #lcsm #ASCO25 WCM Lung Cancer

Final data from the ARROW study reported on the safety and efficacy of pralsetinib for patients with RET-fusion-positive non-small cell #LungCancer (#NSCLC). Ashish Saxena, MD, PhD weighs in on the results which were shared at #ASCO25: bit.ly/3HiDvVy

New York ➡️ Chicago! Excited to see some of our Weill Cornell Medicine @NYPHospital team members at #ASCO25, ready to connect and share insights! Weill Cornell Medicine Meyer Cancer Center WCMHemOncFellow WCM Lung Cancer WCM GI Cancer WCM GU Cancer Weill Cornell Breast Center WCM Cutaneous Oncology